-Search query
-Search result
Showing 1 - 50 of 95 items for (author: murillo & i)
EMDB-41709:
Structure of C-terminal LRRK2 bound to MLi-2
Method: single particle / : Sanz-Murillo M, Villagran-Suarez A, Alegrio-Louro J, Leschziner A
EMDB-41728:
Structure of the C-terminal half of LRRK2 bound to GZD-824 (G2019S mutant)
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
EMDB-41753:
Structure of the C-terminal half of LRRK2 bound to GZD-824 (I2020T mutant)
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
EMDB-41754:
Structure of C-terminal LRRK2 bound to MLi-2 (G2019S mutant)
Method: single particle / : Sanz-Murillo M, Villagran-Suarez A, Alegrio-Louro J, Leschziner A
EMDB-41756:
Structure of C-terminal half of LRRK2 bound to GZD-824
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
EMDB-41757:
Structure of full length LRRK2 bound to GZD-824 (I2020T mutant)
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
EMDB-41758:
Structure of C-terminal LRRK2 bound to MLi-2 (I2020T mutant)
Method: single particle / : Sanz-Murillo M, Villagran-Suarez A, Alegrio Louro J, Leschziner A
EMDB-41759:
Structure of full-length LRRK2 bound to MLi-2 (I2020T mutant)
Method: single particle / : Sanz-Murillo M, Villagran-Suarez A, Alegrio Louro J, Leschziner A
EMDB-41794:
Structure of C-terminal half of LRRK2 (I2020T mutant) bound to GZD-824, Kinase-WD40
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
EMDB-41795:
Structure of C-terminal half of LRRK2 (I2020T mutant) bound to GZD-824, ROC-COR domain
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
EMDB-41797:
Structure of C-terminal half of LRRK2 (G2019S mutant) bound to GZD-824, ROC-COR domain
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
EMDB-41798:
Structure of C-terminal half of LRRK2 bound tp GZFD-824 (G2019S mutant)
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
EMDB-41799:
Structure of C-terminal half of LRRK2 bound to GZD-824 (G2019S mutant), Kinase-WD40
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
EMDB-41802:
Structure of C-terminal half of LRRK2 bound to GZD-824 (I2020T mutant)
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
PDB-8txz:
Structure of C-terminal LRRK2 bound to MLi-2
Method: single particle / : Sanz-Murillo M, Villagran-Suarez A, Alegrio-Louro J, Leschziner A
PDB-8tyq:
Structure of the C-terminal half of LRRK2 bound to GZD-824 (G2019S mutant)
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
PDB-8tzb:
Structure of the C-terminal half of LRRK2 bound to GZD-824 (I2020T mutant)
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
PDB-8tzc:
Structure of C-terminal LRRK2 bound to MLi-2 (G2019S mutant)
Method: single particle / : Sanz-Murillo M, Villagran-Suarez A, Alegrio-Louro J, Leschziner A
PDB-8tze:
Structure of C-terminal half of LRRK2 bound to GZD-824
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
PDB-8tzf:
Structure of full length LRRK2 bound to GZD-824 (I2020T mutant)
Method: single particle / : Villagran-Suarez A, Sanz-Murillo M, Alegrio-Louro J, Leschziner A
PDB-8tzg:
Structure of C-terminal LRRK2 bound to MLi-2 (I2020T mutant)
Method: single particle / : Sanz-Murillo M, Villagran-Suarez A, Alegrio Louro J, Leschziner A
PDB-8tzh:
Structure of full-length LRRK2 bound to MLi-2 (I2020T mutant)
Method: single particle / : Sanz-Murillo M, Villagran-Suarez A, Alegrio Louro J, Leschziner A
EMDB-40803:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40804:
BG505 Boost2 SOSIP.664 in complex with NHP Polyclonal Antibody FP4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40805:
BG505 Boost 2 in complex with NHP antibody V1V2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40806:
BG505 Boost 2 in complex with NHP Polyclonal Antibody N625
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40807:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base1
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40808:
Boost 2 SOSIP.664 in complex with NHP polyclonal antibody Base2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40809:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40810:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8sw7:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-27610:
BG505 MD39 SOSIP in complex with Rh.NJ82 wk13 N611 and base epitope pAbs
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27611:
BG505 MD39 SOSIP in complex with Rh.NJ95 wk13 base epitope pAb
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27612:
BG505 MD39 SOSIP in complex with Rh.NK05 wk13 base epitope pAb
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27614:
BG505 MD39 SOSIP in complex with Rh.NJ79 wk13 base epitope pAb
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27615:
BG505 MD39 SOSIP in complex with Rh.NJ93 wk13 base and V5/C3 epitope pAbs
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27601:
BG505 MD39 SOSIP in complex with Rh.K409 wk13 base, FP/gp41, V5/C3 and N611 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27602:
BG505 MD39 SOSIP in complex with Rh.K487 wk13 base, FP/gp41, and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27603:
BG505 MD39 SOSIP in complex with Rh.DGT5 wk13 base, N335/N289, V1/V3 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27604:
BG505 MD39 SOSIP in complex with Rh.K949 wk33 base, N335/N289, V1/V3, N611 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27605:
BG505 MD39 SOSIP in complex with Rh.L282 wk33 base, N335/N289, FP/gp41 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27607:
BG505 MD39 SOSIP in complex with Rh.DHHT wk33 base, FP/gp41 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27608:
BG505 MD39 SOSIP in complex with Rh.DHID wk33 base, N355/N289 and V1/V3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27609:
BG505 MD39 SOSIP in complex with Rh.NJ78 wk13 V5/C3 and base epitope pAbs
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27600:
BG505 MD39 SOSIP in complex with Rh.L614 wk13 base, N335/N289, V5/C3 and N611 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-26522:
SARS-CoV-2 6P Mut7 in complex with K398.25 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26523:
SARS-CoV-1 in complex with K398.25 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26524:
SARS-CoV-2 6P Mut7 in complex with K398.16 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26525:
SARS-CoV-2 6P Mut7 in complex with K398.16 Fab (3 bound)
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26526:
SARS-CoV-1 in complex with K398.16 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
Pages: